BEAM
Price
$22.74
Change
-$0.70 (-2.99%)
Updated
Apr 24, 6:59 PM EST
12 days until earnings call
PCVX
Price
$60.30
Change
-$0.58 (-0.95%)
Updated
Apr 24, 6:59 PM EST
11 days until earnings call
Ad is loading...

Compare trend and price BEAM vs PCVX

Header iconBEAM vs PCVX Comparison
Open Charts BEAM vs PCVXBanner chart's image
Beam Therapeutics
Price$22.74
Change-$0.70 (-2.99%)
Volume$553.74K
CapitalizationN/A
Vaxcyte
Price$60.30
Change-$0.58 (-0.95%)
Volume$363.54K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs PCVX Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PCVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. PCVX commentary
Apr 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and PCVX is a StrongBuy.

COMPARISON
Comparison
Apr 25, 2024
Stock price -- (BEAM: $22.74 vs. PCVX: $60.88)
Brand notoriety: BEAM and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. PCVX: 93%
Market capitalization -- BEAM: $1.87B vs. PCVX: $6.56B
BEAM [@Biotechnology] is valued at $1.87B. PCVX’s [@Biotechnology] market capitalization is $6.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $567.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 4 bearish.
  • PCVX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -6.46% price change this week, while PCVX (@Biotechnology) price change was -2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.28%. For the same industry, the average monthly price growth was -4.58%, and the average quarterly price growth was +1260.14%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

PCVX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for PCVX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PCVX($6.56B) has a higher market cap than BEAM($1.87B). PCVX YTD gains are higher at: -3.981 vs. BEAM (-16.458).
BEAMPCVXBEAM / PCVX
Capitalization1.87B6.56B29%
EBITDAN/AN/A-
Gain YTD-16.458-3.981413%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMPCVX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PCVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRKAX13.040.12
+0.93%
MFS Blended Research Em Mkts Eq A
SMUYX9.570.01
+0.10%
SEI Multi-Strategy Alternative Y (SIMT)
TWDAX16.390.01
+0.06%
Templeton World Adv
AIEAX18.40-0.02
-0.11%
American Beacon International Eq A
HCAIX96.08-0.40
-0.41%
Harbor Capital Appreciation Inv

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with FOLD. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then FOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-0.95%
FOLD - PCVX
46%
Loosely correlated
-1.59%
INZY - PCVX
45%
Loosely correlated
N/A
MLYS - PCVX
45%
Loosely correlated
-0.61%
XNCR - PCVX
45%
Loosely correlated
+3.54%
ARVN - PCVX
44%
Loosely correlated
-4.29%
More